Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection

Antibody-mediated rejection (AMR) is the main barrier to renal graft survival, and mouse renal AMR models are important to study this process. Current mouse models are established by priming the recipient to donor skin for over 7 days before kidney transplantation. The robustness of AMR in these cas...

Full description

Bibliographic Details
Main Authors: Daqiang Zhao, Tao Liao, Siwen Li, Yannan Zhang, Haofeng Zheng, Jing Zhou, Fei Han, Yu Dong, Qiquan Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.01356/full
id doaj-3b4bd71d95ad415481a2910bdb6d0b24
record_format Article
spelling doaj-3b4bd71d95ad415481a2910bdb6d0b242020-11-24T21:16:11ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-07-01910.3389/fimmu.2018.01356356612Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated RejectionDaqiang Zhao0Tao Liao1Siwen Li2Yannan Zhang3Haofeng Zheng4Jing Zhou5Fei Han6Yu Dong7Qiquan Sun8Division of Kidney Transplantation, Department of Surgery, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDivision of Kidney Transplantation, Department of Surgery, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDivision of Kidney Transplantation, Department of Surgery, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDivision of Kidney Transplantation, Department of Surgery, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDivision of Kidney Transplantation, Department of Surgery, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Pathology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDivision of Kidney Transplantation, Department of Surgery, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Pathology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDivision of Kidney Transplantation, Department of Surgery, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaAntibody-mediated rejection (AMR) is the main barrier to renal graft survival, and mouse renal AMR models are important to study this process. Current mouse models are established by priming the recipient to donor skin for over 7 days before kidney transplantation. The robustness of AMR in these cases is too strong to mimic clinical AMR and it is unclear why altering the priming times ranging from 7 to 91 days fails to reduce the AMR potency in these models. In the present study, we found that the donor-recipient combination and skin graft size were determinants of donor-specific antibody (DSA) development patterns after skin transplantation. DSA-IgG was sustained for over 100 days after skin challenge, accounting for an identical AMR robustness upon different skin priming times over 7 days. However, decreasing the skin priming time within 7 days attenuated the robustness of subsequent renal allograft AMR in C3H to Balb/c mice. Four-day skin priming guaranteed that recipients develop acute renal AMR mixed with a high ratio of graft-infiltrating macrophages, renal grafts survived for a mean of 6.4 ± 2.1 days, characterized by typical AMR histological changes, such as glomerulitis, peritubular capillary (PTC) dilation, and capillaritis, deposition of IgG and C3d in PTCs, but less prevalence of microthrombus, whereas the cellular rejection histological change of tubulitis was absent to mild. With this scheme, we also found that the renal AMR model can be developed using common mouse strains such as C57BL/6 and Balb/c, with mean prolonged renal graft survival times of 14.4 ± 5.0 days. Finally, we proved that donor-matched skin challenge after kidney transplantation did not strongly affect DSA development and kidney graft outcome. These findings may facilitate an understanding and establishment of mouse renal allograft AMR models and promote AMR-associated studies.https://www.frontiersin.org/article/10.3389/fimmu.2018.01356/fullkidney transplantationantibody-mediated rejectiondonor-specific antibodyanimal modelmice
collection DOAJ
language English
format Article
sources DOAJ
author Daqiang Zhao
Tao Liao
Siwen Li
Yannan Zhang
Haofeng Zheng
Jing Zhou
Fei Han
Yu Dong
Qiquan Sun
spellingShingle Daqiang Zhao
Tao Liao
Siwen Li
Yannan Zhang
Haofeng Zheng
Jing Zhou
Fei Han
Yu Dong
Qiquan Sun
Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection
Frontiers in Immunology
kidney transplantation
antibody-mediated rejection
donor-specific antibody
animal model
mice
author_facet Daqiang Zhao
Tao Liao
Siwen Li
Yannan Zhang
Haofeng Zheng
Jing Zhou
Fei Han
Yu Dong
Qiquan Sun
author_sort Daqiang Zhao
title Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection
title_short Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection
title_full Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection
title_fullStr Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection
title_full_unstemmed Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection
title_sort mouse model established by early renal transplantation after skin allograft sensitization mimics clinical antibody-mediated rejection
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2018-07-01
description Antibody-mediated rejection (AMR) is the main barrier to renal graft survival, and mouse renal AMR models are important to study this process. Current mouse models are established by priming the recipient to donor skin for over 7 days before kidney transplantation. The robustness of AMR in these cases is too strong to mimic clinical AMR and it is unclear why altering the priming times ranging from 7 to 91 days fails to reduce the AMR potency in these models. In the present study, we found that the donor-recipient combination and skin graft size were determinants of donor-specific antibody (DSA) development patterns after skin transplantation. DSA-IgG was sustained for over 100 days after skin challenge, accounting for an identical AMR robustness upon different skin priming times over 7 days. However, decreasing the skin priming time within 7 days attenuated the robustness of subsequent renal allograft AMR in C3H to Balb/c mice. Four-day skin priming guaranteed that recipients develop acute renal AMR mixed with a high ratio of graft-infiltrating macrophages, renal grafts survived for a mean of 6.4 ± 2.1 days, characterized by typical AMR histological changes, such as glomerulitis, peritubular capillary (PTC) dilation, and capillaritis, deposition of IgG and C3d in PTCs, but less prevalence of microthrombus, whereas the cellular rejection histological change of tubulitis was absent to mild. With this scheme, we also found that the renal AMR model can be developed using common mouse strains such as C57BL/6 and Balb/c, with mean prolonged renal graft survival times of 14.4 ± 5.0 days. Finally, we proved that donor-matched skin challenge after kidney transplantation did not strongly affect DSA development and kidney graft outcome. These findings may facilitate an understanding and establishment of mouse renal allograft AMR models and promote AMR-associated studies.
topic kidney transplantation
antibody-mediated rejection
donor-specific antibody
animal model
mice
url https://www.frontiersin.org/article/10.3389/fimmu.2018.01356/full
work_keys_str_mv AT daqiangzhao mousemodelestablishedbyearlyrenaltransplantationafterskinallograftsensitizationmimicsclinicalantibodymediatedrejection
AT taoliao mousemodelestablishedbyearlyrenaltransplantationafterskinallograftsensitizationmimicsclinicalantibodymediatedrejection
AT siwenli mousemodelestablishedbyearlyrenaltransplantationafterskinallograftsensitizationmimicsclinicalantibodymediatedrejection
AT yannanzhang mousemodelestablishedbyearlyrenaltransplantationafterskinallograftsensitizationmimicsclinicalantibodymediatedrejection
AT haofengzheng mousemodelestablishedbyearlyrenaltransplantationafterskinallograftsensitizationmimicsclinicalantibodymediatedrejection
AT jingzhou mousemodelestablishedbyearlyrenaltransplantationafterskinallograftsensitizationmimicsclinicalantibodymediatedrejection
AT feihan mousemodelestablishedbyearlyrenaltransplantationafterskinallograftsensitizationmimicsclinicalantibodymediatedrejection
AT yudong mousemodelestablishedbyearlyrenaltransplantationafterskinallograftsensitizationmimicsclinicalantibodymediatedrejection
AT qiquansun mousemodelestablishedbyearlyrenaltransplantationafterskinallograftsensitizationmimicsclinicalantibodymediatedrejection
_version_ 1726016574138089472